THE PROBLEM AND RESOLUTION OF THE OPIOID ADDICTION EPIDEMIC - CHARLES H. PIERCE, MD, PHD, FCP, CPI - COLLEGE OF MEDICINE
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
The Problem and Resolution of the Opioid Addiction Epidemic Charles H. Pierce, MD, PhD, FCP, CPI University of Saskatchewan College of Medicine, Class of 1968 1 March 07
Disclosure I confirm that I have no financial relationship or conflict of interest in relation to this talk- educational activity ... just the will to educate and that to your right... 2
Learning Objectives ▶ Understand the nature and management of Opioid Addiction ▶ Describe the most effective way to view the Addict ▶ Compare the addictions of the many different agents ▶ Explain why Buprenorphine is effective in the management of Opioid Addiction ▶ Determine the method of discontinuing the Buprenorphine program ▶ Evaluate your success in changing a life 3
Topics/Areas I will cover ▶ What is this disease called “Addiction”? ▶ Role of cigarette smoking? An Addiction ▶ Is Marijuana included as an Addiction? ▶ What’s this Drug / Opioid Epidemic all about? ▶ The Treatment / Management of Addiction ▶ The Role of us Docs in this epidemic? 4
Disease = Addiction ? ▶ Definition of “Disease”: Any deviation from or interruption of the normal structure or function of any body part, organ, or system that is manifested by a characteristic set of symptoms and signs and whose etiology, pathology, and prognosis may be known or unknown. ▶ ASAM Definition of the “Disease of Addiction”: addiction is a primary, chronic disease of the brain reward, motivation, memory and related circuitry. Dysfunction in these circuits leads to characteristic biological, psychological, social and spiritual manifestations. ▶ The definition fits and both can be fatal without treatment. SUD costs Americans >$700 Billion/year in increased health care costs, crime, and lost productivity 6
Addiction is a Disease - of the Brain ▶ Addiction is a chronic relapsing brain condition with strong genetic and environment components that affects memory, motivation and inhibition... ▶ This is a physical condition, not caused by a lack of willpower or morals and not cured by good advice. ▶ Substance Use Disorder (SUD) is a general CNS disease as over time, nerve cells in the brain ‘learn’ to crave opiates and other substances. ▶ SUD: a chronic & treatable disease affecting 20.8 M Americans, like diabetes and heart disease and should be viewed from the same portal. 7
Genetic factors account for between 44-60 % of a person's vulnerability to addiction, including the effects of environment on gene expression and function.
Substance Use Disorder / Addiction ? The Hallmarks of the SUD / Addiction epidemic ▶ Genetic and environmental factors ▶ Chronic and relapsing - by definition ▶ Craving and binging - a hallmark ▶ Brain and chemistry changes ▶ Tolerance requiring more of the same for effect ▶ Drug availability: parents, friends have influence ▶ Consequences include stigmatization 9
For SUD: Language Matters Stigmatizing words and Phrases should be discouraged and replaced in the minds of everyone ... ‘Abuser’ ▶ negates that SUD is a medical condition and ignores the environmental, genetic and psychological factors ▶ Tends to absolve the supplier. ▶ Use ‘misuse’, ‘inappropriate use’, ‘hazardous use’, ‘problem use’, ‘risky use’ ‘Addict’, ‘Drug Addict’, ‘Junkie’, ‘Degenerate’, ‘Dope Fiend’, ‘Crackhead’ should never be used/considered ▶ No distinction between the person and their disease ▶ Denies the dignity and humanity of the individual ▶ Suggests permanency. 10
Opioid Use Disorder - Criteria 1.Opioids taken in larger amounts/longer time than intended 2. Persistent/unsuccessful desire / efforts to cut down dose 3. Excess time is spent to obtain, use or recover from effects 4.Craving, or a strong desire or urge to use opioids 5.Recurrent use resulting in failure to fulfill roles at work, home 6.Continued use despite social / interpersonal problems caused 7. Social, occupational or recreational activities reduced due to.. 8. Recurrent opioid use in situations that may be hazardous 9. Continued use despite persistent or recurrent physical or psychological problem most likely cause by the substance 10.Tolerance i.e. a need to increase the amount for effect and a diminished effect by the same dose 11.Physical Dependence... 11
Ask and you will know Questions I ask every patient as they start MAT Have you ever overdosed? Ever given Narcan? How old were you when you first became addicted? How did you start? – with what agents? Did either of your parents have a problem with ... ? Does your partner have trouble with drugs or alcohol? Are you presently working? Do you use Marijuana? For how long? Do you smoke or chew tobacco? For how long? 12
How Did the Epidemic Start? ▶ Addiction is an medical state or condition that is partially Doctor induced. ▶ 91,000,000 Rx in 1991 to ▶ 219,000,000 Rx in 2011 to ▶ 300,000,000 Rx in 2017 In 2017 the US experienced a 12% drop in prescription Opioid dosage volume, which was the steepest annual decline in 25 years I ask every patient I see how and when they first realized they were addicted and how. The answers will surprise everyone. 13
Canada Leads North America There are a number of items/programs that Canada is ahead of the US in: ▶ In March of 2016, the Canada made the overdose- reversal drug naloxone a non-prescription agent! ▶ In BC, naloxone is available at no cost through community agencies and pharmacies. Basis of need ▶ Led by BC, Canada now facilitates the development of medically supervised injection facilities. ▶ BC now funds publicly available anonymous drug- testing services i.e. users can test before using. ▶ Education must apply to all health care providers 14
Risk Factors for Opioid Abuse ▶ Use of Prescription controlled opiate agents and/or Benzodiazepines ▶ Use of Alcohol and Tobacco ▶ History of Sexual Abuse female > male ▶ Familyhistory of Substance Abuse or a Psychiatric disease diagnosis ▶ Age 16 – 45 years and male > female 15
The Opioid Risk Tool (ORT) 1. Family Hx of Substance Abuse F M Alcohol ☐1 ☐3 Illegal Drugs ☐2 ☐3 Prescription Meds ☐4 ☐4 2. Personal Hx of Substance Abuse Alcohol ☐3 ☐3 Illegal Drugs ☐4 ☐4 Prescription Meds ☐5 ☐5 3. Age between 16 and 25 ☐1 ☐1 4. Hx of Adolescent Sexual Abuse ☐3 ☐0 5. Psychological Disease ADD, OCD, BiPolar, Schizoph ☐2 ☐2 Depression ☐1 ☐1 16
Addiction Statistics - 2016 Estimates on the Number of Deaths ▶ Opiates 62,000 >1/3 in age 25-34 years ▶ Alcohol 80,000 ▶ Tobacco 440,000 Probability of ‘Addiction’ after the First Use ▶ Tobacco 32% ▶ Heroin 23% ▶ Cocaine 17% ▶ Alcohol 15% ▶ Cannabis 9% 17
Cigarette Smoking Smoking two packs of cigarettes daily is linked to an almost fivefold risk of stroke. 18 August 05
The Addiction of Smoking 90% of smokers start in their teens with the average age of Starting at 13-15 Years old Why? ▶ Advertising ▶ Endorsement ▶ Product Placement ▶ Special Tobacco Formula ▶ To be ‘cool’ ▶ Because my friend does it ▶… 19
Must Really be “Cool” to Smoke A 20
Believe it or not 21
The End-Result of Nicotine Use “Nicotine addiction is the second- leading cause of death worldwide.” The important causes of smoking- related mortality are atherosclerotic cardiovascular disease, cancer, and chronic obstructive pulmonary disease (COPD). Forewarned is Forearmed Ref: www.CDC.gov 22
What to you get for your money?? Bad Breath Lung Problems ▶ Emphysema ▶ COPD Marked increase in Heart Disease (#1 Killer) Marked increase in Cancer ▶ Lung ▶ Throat ▶ Mouth ▶ Stomach ▶ Intestinal And on and on… every part of your body. 23
Recommended Office Poster
Marijana / Marihuana 25 August 05
Cannabis is a lot more than THC The Cannabis plant includes more than 400 different chemicals, of which about 70 are cannabinoids. ▶ Typical government-approved medications contain only one or two chemicals. ▶ The number of active chemicals in cannabis is one reason why treatment with cannabis is difficult A 2014 review stated that the variations in ratio of CBD-to-THC in botanical and pharmaceutical preparations determines the therapeutic vs psychoactive effects (CBD attenuates THC's psychoactive effects) of cannabis products 26
Cannabinoids Pharmacologically active ingredients THC: Δ9-Tetrahydrocannabinol ▶ Euphoria and psychosis ▶ Marinol® to improve appetite Cannabidiol (CBD) ▶ Not Psychoactive ▶ POSSIBLE Antianxiety & Antipsychotic Therapeutic effects vary greatly ▶ Depend on [THC] ▶ Ratio of THC:Cannabidiol ü Cannabidiol can mitigate psychoactive effects of THC 27
Legal status of Marijuana A Ref: 28
. 29
Use of Drugs leading to SUD What agents started an individual down the path of wanting and using illicit drugs (study of 2.8M with SUD) ▶ Marijuana 70.3% ▶ Pain Relievers 12.5% ▶ Inhalants 6.3% ▶ Tranquilizers 5.2% ▶ Stimulants 2.7% ▶ Hallucinogens 2.6% ▶ Sedatives, Cocaine 0.3% 30
Once Medically Available ... The argument against legalization ▶ Addictive nature is such that 10% of users are likely to develop dependence - increasing HC costs. ▶ Health concerns - The brain, the heart, the lungs, and mental health. This is not to be taken lightly. ▶ After effects such as a distorted perception triggering accidents or as a gateway/start to more serious drugs. ▶ Safety of children who get into almost anything around the house or on the street +/- supervision ▶ Unintended consequences is when added to ‘candy’, an “overdose” is considerably more likely 31
Marijuana Candy and Gummies Is this what you want your kids to consume? 32
The Result of Legal Marijuana A 33
Methamphetamine 34 August 05
Methamphetamine Also called Chalk, Crystal, Glass, Ice, Meth, Speed ... ▶ This is a very addictive stimulant. ▶ It is a pill, powder, crystal that can be ingested, snorted, injected or smoked in a small glass pipe. The METH rush and good feelings get soon replaced by edginess, excitement, anger, fear. “Addiction” follows quickly with increased body temperature, BP, HR, Itching, emotional problems and a big problem in decision making METH and MDMA (2,4 methyldioxyMeth (ecstacy) has a strong relationship to ‘high-risk’ sexual behavior in HIV/AIDS due to judgment Lapses It has been added to Marijuana to the surprise of users 35
The Drug / Opioid Epidemic 36 August 05
Yes, Opioid Addiction is Serious Opioid dependence affects nearly 5 million people in the US and leads to almost 64,000 deaths annually (2016). According to the CDC, the death rate from overdose tripled from 6.1/100,000 in 1999 to 19.8/100,000 in 2016. Number of fatal overdosing from Fentanyl and other synthetic opiates more than doubled from 2015 (9K) to 2016 (19K) Half of the deaths due to drug overdose are related to Rx. 80% of Heroin users report misusing prescription opioids prior to heroin. 37
“Addiction” Starts in Many Ways Individuals who have an “addiction” to: ▶ Alcohol are 2 times... ▶ Marijuana are 3 times... ▶ Cocaine are 15 times... ▶ Pain Reliever Meds are 40 times... ... More likely to get addicted to Heroin than others It is said that 4 of 5 heroin users started out being prescribed opioid pain medications 38
For Every Problem, A Solution ▶ Too Many Prescriptions - in 2015 enough was prescribed to cover every American for 3 weeks – 640 MME per person Fewer Prescriptions - use only when benefits likely to outweigh the risk. Consider Non Opioid and/or PT... ▶ Too Many Days Rx - more than 3 months increases the risk of addiction 15 times Fewer Days of Rx - consider 3-4 days and taper ▶ Too High a Dose – Doses > 50 MME per day doubles the risk of Overdose. Doses at 90 MME Increase the risk 10 times Lower Dosage Rx – Use lowest effective dose of immediate release agents. Avoid a daily dose of 90 MME or more or taper to a safer dose 39
New Prescribing Rules (MD, DO, PA) 1. No more than 7 day Rx on First Prescription (Rx) 2. No more than 5 day Rx for minors + parent consent 3. No excess of the days supply unless patient records clearly document a valid reason 4. Total MED of Rx cannot exceed avg. 30 MED/day 5. Limits do not apply to opioids Rx for cancer, palliative care, end of life/hospice care or ... In addition, on the RX there must be at least 4 of the 7 ICD-10 code digits for the Diagnosis or Procedure and the number of days supply - actually written on the Rx 40
ICD-10 Codes typically used F11.20 Opioid dependence, uncomplicated ✔ F11.21 Opioid dependence, in remission ✔ F12.19 Cannabis abuse with unspecified cannabis-Anxiety F12.92 Cannabis use, unspecified with intoxication F14.90 Cocaine use, unspecified, uncomplicated F15.10 Other stimulant abuse, uncomplicated (METH, Amph) F17.201 Nicotine dependence, cigarettes, uncomplicated F41.9 Anxiety Disorder, unspecified F43.10 Post-traumatic stress disorder, unspecified N94.3 Premenstrual Tension syndrome O09.33 Tobacco use (smoking) during pregnancy, childbirth.. B19.2 Unspecified viral hepatitis C 41
Where to Individuals Get Opioids The source of the most recent Opioid: ▶ 54% Given, bought, or taken from a friend or Relative ▶ 36% By a Rx or stolen from a Health Care Provider ▶ 5% Bought from a Dealer or Stranger ▶ 5% other than the above Ref: SAMSA 2015 42
Drug Source relationship A Ref: SAMHSA, cited in Tetrault, Butner, 2015 43
What are the Common Opiates? . methadone Dolophine heroin hydromorphone Dilaudid Morphine Buprenorphine MS Contin Suboxone/Subutex Bunavail/ Zubsolv hydrocodone Vicodin Codeine Tylenol # 3 oxycodone Oxycontin & Percocet 44
And then there is Fentanyl + Fentanyl and fentanyl analogues include the following: ▶ Fentanyl* (65% of T) ▶ despropionyl-fentanyl ▶ acetylfentanyl ▶ furanyl-fentanyl ▶ butyrylfentanyl ▶ Norfentanyl ▶ Carfentanil ▶ 3-methylfentanyl Many of these show up when least expected and OD deaths from Fentanyl is considered and advertisement Keep in mind that even metabolites can be active: ▶ Dihydrocodeine ▶ Monoacetylmorphine ▶ Norbuprenorphine 45
Fentanyl !!! ▶ TheOMHAS has issued an advisory (21Feb18) on the marked increase of “fentanyl-related OD deaths when non-opioids are known to be involved ▶ One of the 20+ forms of Fentanyl has been found in ▶ Heroin ▶ Cocaine - (powdered Crack) ▶ Marijuana ▶ Methamphetamine ▶ MDMA - (powdered Estacy) ▶ Rx? opioids, sedatives, and hypnotics We now administer naloxone in all drug overdoses as the Liklihood of Fentanyl is that high! 46
Opioid Potency Fentanyl & Carfentanil often in Marijuana èè 47
How Bad is the Opioid Epidemic? This “Epidemic” has been called the worst drug crisis in American and Canadian History with deaths now rivaling those from AIDS in the 1990s ▶ In ‘99 there was more than twice as many motor vehicle deaths as fatal drug overdoses. ▶ These numbers flipped in 2008 and by 2014 there was almost 40 percent more deaths from overdoses (47,055) than car crashes (29,230) ▶ Cocaine used to be the leading killer but now Heroin and prescription opioids lead. * ▶ By 2014 Opioid deaths were up 369% and Heroin deaths were up 439% 48
Some Surprises from the CDC A 49
▶P Age-adjusted drug overdose Death rates by state, 2016 50
Rx / 100 Persons in US A 199 MME in 1999 640 MME by 2015 51
▶ Age-adjusted drug overdose Death rates by Province, 2016 52
Canada Leads North America There are a number of items/programs that Canada is ahead of the US in: ▶ In March of 2016, the Canada made the overdose- reversal drug naloxone a non-prescription agent! ▶ In BC, naloxone is available at no cost through community agencies and pharmacies. Basis of need ▶ Led by BC, Canada now facilitates the development of medically supervised injection facilities. ▶ BC now funds publicly available anonymous drug- testing services i.e. users can test before using. ▶ Education must apply to all health care providers 53
Age adjusted Death Rates ▶P 54
OD Death Rates by Age group 55
Overdose kills Actual case in 2016 56
“You are not alone” Over 800,000 people in the US are dependent on heroin or other opiates. The number in Canada is a similar percentage of the population as in the US For an overdose (OD) there is naloxone* (Narcan, Evzio), 0.4-2 mg iv/im/subq not to exceed 10 mg which is available in several forms: ▶ Narcan - 4mg/actuation non aerosol spray ▶ naloxone - 0.4 mg/ml soln. or 1.0 mg/ml syringe ▶ Evzio - 0.4 mg/0.4 ml auto-injector, 2.0 mg/0.4 ml *Available in Canada without a Prescription/OTC 57
Treatment / Management of Drug Addiction 58 August 05
Medicated Assisted Treatment ▶ MAT is the use of medications, in combination with counseling and behavioral therapies, to provide a “whole patient” approach to the treatment of SUD ▶ The combination of meds and therapy is successful in treating those struggling with addiction. ▶ MAT is used primarily for the treatment of addiction to opioids (Heroin and Rx pain meds with opioids) The meds normalize brain chemistry and block the euphoric effects, relieve physiologic craving, and normalize body functions without the negative effects. 59
Drug Abuse Treatment Act (DATA) When prescribing buprenorphine et al TO TREAT ADDICTION, a physician must have a DATA 2000 Waiver, also called an “X-DEA number” à Ref: 21 U.S.C. 823(g) DATA 2000 Waiver can be obtained by any physician by taking an 8-hour online course and passing a test. You can treat 30 patients/yr. with buprenorphine et al in year 1, and 100 patients/yr. starting in year 2, and from Aug 2016 275 Patients/yr. from year three on. Ref: http://www.samhsa.gov/medication-assisted-treatment As of 14Feb18 there are only 46,500 waivered docs Ref: MedPage Today February 14, 2018 60
Certified Physicians by Waiver Level DEA As ofCertified MD/DO (n=41,170) March 2018 30 (28,068) 100 (9,110) 275 (3,992) 10% 22% 68% Capacity: 2,850,840 March 2018 61
Clinical Opiate Withdrawal Scale To determine the withdrawal state prior to Rx ▶ Resting Heart Rate ▶ GI Upset ▶ Sweating ▶ Tremor ▶ Restlessness ▶ Yawning ▶ Pupil size ▶ Anxiety or Irritability ▶ Bone or Joint aches ▶ Goose Flesh skin ▶ Runny nose or tearing Total score ______ 5-12=mild, 13-24=moderate, 25-36=moderately severe, >36=wow 62
Use of Buprenorphine Buprenorphine blocks other opiates and prevents physical craving for those opiates. Many people describe feeling “normal” or “energized” when they take their buprenorphine regularly. ▶ Buprenorphine: is an opiate that acts to fill up the brains opiate mu receptors without causing sleepiness or “high” feelings. It has a low risk of overdose. ▶ Naloxone: a drug that is not absorbed orally but helps persuade people to not inject Suboxone in a vein as it causes instant withdrawal. 63
Buprenorphine Knowledge ▶ BUP is a semisynthetic, highly lipophilic thebaine derivative, which is a Partial µ-agonist but > naloxone and an antagonist at the kappa receptors ▶ Mu-opioid receptor activity produces the analgesic effects of BUP, which is 25-50 times more potent than morphine. ▶ BUP is metabolized through the CYP3A4 system so attention must be paid to the potential for significant drug interactions among other meds that are substrates, inhibitors, or inducers of his system. 64
Buprenorphine (BUP) Products Buprenorphine is a unique opioid analgesic that comes in many dosage formulations - most transmucosal use 1. Suboxone® - BUP/Naloxone - sl film, 2/.5, 4/1, 8/2, 12/3 mg 2. Buprenorphine/Naloxone - (generic) - sl tablet, 2/.5, 8/2 mg 3. Bunavail® - BUP/Nalox - buccal film, 2.1/.3, 4.2/.7, 6.3/1 mg 4. Zubsolv® - BUP/Nalox - sl tablet 1.4/.36, 5.7//1.4 mg 5. Buprenorphine - BUP (generic) – sl tablet 2, 8 mg 6. Subutex® - BUP - sl tablet, 2, 8 mg 7. Buprenex® - BUP – iv, im, 0.3 mg/ml 8. Sublocade® - BUP - subq injection/month, 300 mg, then 100 mg 9. Probuphine® - BUP - an implant, 74.2 (80) mg X 4 65
The half-life is around 36 hours i.e. taken once a day it takes a week for maximum effect or to be eliminated 66
How to take tablet or the strips (film)* Plan on 35-40 minutes of “Quiet Time” alone Do not smoke for 20-30 minutes prior to taking the medication as tobacco is a vaso-constrictor thus inhibiting absorption. Rinse your mouth with warm water (vasodilator) prior to taking the dose, which promotes absorption After placing the tablet or strip under your tongue, to ensure absorption of the agent (Buprenorphine) you need, for 15-20 Minutes you must: ▶ Not drink anything ▶ Not smoke or use any form of tobacco ▶ Not swallow the tablet remains or your saliva 67
Screening Tests Each Visit Systems vary but the following are tested regularly ▶ BUP -Buprenorphine ▶ OPI- Opiates ▶ AMP -Amphetamine ▶ MOP -Heroin ▶ MET -Methamphetamine ▶ COC -Cocaine ▶ BZO -Benzodiazepine ▶ BAR -Barbiturates ▶ OXY -Oxycodone ▶ THC -Marijuana ▶ TCA -Tricyclic Antidepress. ▶ MTD -Methadone On Further testing? ng/ml on above plus surprises ▶ Norbuprenorphine ▶ MDMA (estacy) ▶ Gabapentin ▶ Pregablin ▶ Fentanyl !!! 68
Meds NOT to be taken with BUP Benzodiazepine’s top the list: ▶ Valium (diazepam) ▶ Ativan et al (lorazepam) ▶ Xanax et al (alprazolam) ▶ Klonopin (clonazepam) ▶ Celexa (citalopram) ▶ Ambien et al (zolpidem) ▶ Adderall (amph/dextroamph) ▶ Catapress et al (clonidine) ▶ Cymbalta (duloxetine) ▶ Flexeril (cyclobenzaprine) A total of 1047 drugs (5868 brand and generic names) have been fund to interact with Buprenorphine 69
Along with Buprenorphine Stopping the Physical craving is just the beginning Changing thinking followed by the behaviors associated with the SUD is the process of “Recovery” Recovery process requires Psychological and Psychiatric Counseling/therapy. Group counseling has the advantage as the patient sees beyond her/himself Individual Counseling plus Group-therapy may be the only way to learn to cope with the pain, blame and shame linked to addiction. It is a safe and tested way to treat depression or to face abuse that may have occurred in the patients past. 70
Now You Know Thank you for listening In the US- FDA = 800-332-1088 Health Canada = 866-234-2345 http://Dr.Pierce1.net Charles@Pierce1.net 71
Selected References ▶ American Society of Addiction Medicine Opioid Addiction (2016) Facts & Figures http://www.asam.org/docs/default-source/advocacy/opioid-addiction- disease-facts-figures.pdf ▶ Dowell D, Haegerich TM, Chou R. (2016) CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016. MMWR Recomm Rep 2016;65(No. RR-1):1–49. DOI: http://dx.doi.org/10.15585/mmwr.rr6501e1 ▶ National Institute on Drug Abuse (NIDA) https://www.drugabuse.gov/ ▶ Rebecca Voelker, MSJ (2018,) Monthly Buprenorphine Injection Approved for Opioid Use Disorder,. JAMA. 2018;319(3):220. doi:10.1001/jama.2017.20647 ▶ Physician Clinical Support System (PCSS)-National Mentor for Physicians Treating Opiate Dependence. http://www.PCSSmentor.org ▶ Joshi V, Suchin, V, Lim, J, (2017), Smoking Cessation: Barriers, Motivations and the role of Physicians - A Survey of Physicians and patients, Sing Health Center for Health Serv. Res. ▶ Pierce, CH, (2018) The Pre-Menstrual (PMS) Treatment is Unmasked and it is Simple and Safe. Arch Clin Med Case Rep.; 2(1):1-4 doi: 10.26502/acmcr.016 72
Selected References ▶ Hedegaard H, Warner M, Miniño AM. (2017) Drug overdose deaths in the United States, 1999-2016. NCHS Data Brief, no 294. Hyattsville, MD: National Center for Health Statistics ▶ Rudd RA, Seth P, David F, Scholl L. (2016) Increase in drug and Opioid-involved overdose deaths-United States, 2010-2015. MMWR Morbidity Wkly Rep 65:1445-52 ▶ CDC. Increases in Drug and Opioid Overdose Deaths — United States, 2000– 2015. CDC (2016). https://www.cdc.gov/mmwr/volumes/65/wr/mm655051e1.htm. ▶ American Psychiatric Association. (2013) Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Washington, DC: American Psychiatric Association; 541-46 ▶ National report: Apparent opioid-related deaths in Canada (December 2017) https://www.canada.ca/en/public-health/services/publications/healthy-living/ apparent-opioid-related-deaths-report-2016-2017-december.html ▶ Zoorob, R, Kowalchuk, A, Mejia de Grubb, M, (2018) Buprenorphine Therapy for Opioid Use Disorder; American Family Physician, 97(5), p 313-320 73
Selected References ▶ Dowell D, Haegerich TM, Chou R. CDC (2016), Guideline for Prescribing Opioids for Chronic Pain - United States, MMWR Recomm Rep 2016;65(No. RR-1):1–49. doi: http://dx.doi.org/10.15585/mmwr.rr6501e1 ▶ Medication Assisted Treatment http://www.samhsa.gov/medication-assisted-treatment ▶ National Institute on Drug Abuse (NIDA) https://www.drugabuse.gov/ ▶ SchuckitMA. (2016) ,Treatment of Opioid Use Disorders. NEJM 375(4), 357 http://www.nejm.org/doi/full/10.1056/NEJMra1604339#t=article ▶ Substance Abuse and Mental Health Services Administration. (2017), Opioid Use in the Older Population. Rockville, MD ▶ Substance Abuse and Mental Health Services Administration. (2011), Managing Chronic Pain in Adults With or in Recovery From Substance Use Disorders. Treatment Improvement Protocol (TIP) Series 54. HHS Publication No. (SMA) 12-4671. Rockville, MD: ▶ EmergencyDepartment Data Show Rapid Increases in Opioid Overdoses – Wake-up call to the fast-moving opioid overdose epidemic; CDC VitalSigns 2017 74
Selected References ▶Gomes T, Greaves S, Martins D, et al (2017) Latest trends in Opioid- Related Deaths in Ontario: 1991-2015. Ontario Drug Policy Research Network, Toronto, ON ▶British Columbia Coroners service. (2017) Illicit Drug overdose Deaths in BC. January 1, 2007-March 31, 2017. British Columbia Coroners Service, Burnaby, BC ▶Wood E, MD, PhD, (2018) Strategies for Reducing Opioid-Overdose Deaths Lessons from Canada. N Engl J Med, 378:1565-1567 doi: 10.1056/NEJMp1800216 ▶Buprenorphine Information: www.buprenorphine.samhsa.gov ▶Waiver Training: http://pcssnow.org ▶Waiver information: http://bit.ly/docwaiver ▶The Pharmacology of MAT http://bit.ly/tip63mat 75
You can also read